| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 67.15B | 72.97B | 67.38B | 72.71B | 83.87B | 70.79B |
| Gross Profit | 28.72B | 31.30B | 26.21B | 27.93B | 36.49B | 27.63B |
| EBITDA | 8.77B | 11.17B | 8.73B | 11.17B | 18.49B | 13.83B |
| Net Income | 1.94B | 3.87B | 1.78B | 4.41B | 10.14B | 7.89B |
Balance Sheet | ||||||
| Total Assets | 105.29B | 113.57B | 107.22B | 107.14B | 104.23B | 94.96B |
| Cash, Cash Equivalents and Short-Term Investments | 16.42B | 18.17B | 19.21B | 17.63B | 18.41B | 17.90B |
| Total Debt | 25.03B | 27.36B | 26.22B | 25.24B | 25.49B | 25.49B |
| Total Liabilities | 41.79B | 43.65B | 43.40B | 41.13B | 45.42B | 45.95B |
| Stockholders Equity | 63.50B | 69.92B | 63.81B | 66.01B | 58.81B | 48.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.09B | 2.39B | 3.70B | 4.42B | 7.93B |
| Operating Cash Flow | 0.00 | 7.44B | 11.25B | 5.50B | 7.01B | 9.65B |
| Investing Cash Flow | 0.00 | -5.30B | -4.10B | -1.92B | -3.11B | -1.29B |
| Financing Cash Flow | 0.00 | -3.69B | -2.90B | -4.46B | -4.40B | -8.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥275.81B | 9.01 | 8.91% | 3.85% | 5.98% | 39.06% | |
76 Outperform | ¥351.00B | 16.17 | 7.67% | 0.91% | 11.51% | 46.17% | |
74 Outperform | ¥100.84B | 18.23 | 7.00% | 3.02% | 8.49% | -0.33% | |
67 Neutral | ¥94.17B | 25.51 | ― | 4.45% | 8.29% | 117.44% | |
65 Neutral | ¥203.30B | 14.94 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | ¥93.64B | 29.26 | 5.02% | 3.23% | -21.03% | -91.77% |